Banco Bilbao Vizcaya Argentaria’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-25,000
Closed -$114K 767
2020
Q2
$114K Hold
25,000
﹤0.01% 737
2020
Q1
$90K Buy
+25,000
New +$138K ﹤0.01% 653

Other funds holding ZVRA

Banco Bilbao Vizcaya Argentaria's ZVRA Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Zevra Therapeutics (ZVRA) in Q3 2020, closing a stake of 25,000 shares — an estimated $114K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in ZVRA in Q1 2020 and held it in 2 quarters. The position peaked at $114K in Q2 2020. 2 funds tracked by Wall St. Rank hold ZVRA as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Zevra Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 25,000 Zevra Therapeutics shares in Q3 2020, an estimated $114K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Zevra Therapeutics in Q1 2020 and held it in 2 quarters.
  • Banco Bilbao Vizcaya Argentaria's Zevra Therapeutics position peaked at $114K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.